| pubmed-article:20832374 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20832374 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:20832374 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:20832374 | lifeskim:mentions | umls-concept:C0443315 | lld:lifeskim |
| pubmed-article:20832374 | lifeskim:mentions | umls-concept:C1533685 | lld:lifeskim |
| pubmed-article:20832374 | lifeskim:mentions | umls-concept:C0021641 | lld:lifeskim |
| pubmed-article:20832374 | lifeskim:mentions | umls-concept:C0184511 | lld:lifeskim |
| pubmed-article:20832374 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:20832374 | lifeskim:mentions | umls-concept:C0021677 | lld:lifeskim |
| pubmed-article:20832374 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:20832374 | lifeskim:mentions | umls-concept:C1514923 | lld:lifeskim |
| pubmed-article:20832374 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:20832374 | pubmed:dateCreated | 2010-12-7 | lld:pubmed |
| pubmed-article:20832374 | pubmed:abstractText | This study was a real-world, retrospective evaluation of the clinical effectiveness of switching to continuous subcutaneous insulin infusion (CSII) among managed care enrollees with type 2 diabetes for whom multiple daily injections (MDI) had presumably failed. | lld:pubmed |
| pubmed-article:20832374 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20832374 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20832374 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20832374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20832374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20832374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20832374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20832374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20832374 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20832374 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:20832374 | pubmed:issn | 1751-9918 | lld:pubmed |
| pubmed-article:20832374 | pubmed:author | pubmed-author:FanYingY | lld:pubmed |
| pubmed-article:20832374 | pubmed:author | pubmed-author:LevinsonJenif... | lld:pubmed |
| pubmed-article:20832374 | pubmed:author | pubmed-author:LeeScott WSW | lld:pubmed |
| pubmed-article:20832374 | pubmed:author | pubmed-author:SamantNavendu... | lld:pubmed |
| pubmed-article:20832374 | pubmed:author | pubmed-author:RiedelAylin... | lld:pubmed |
| pubmed-article:20832374 | pubmed:author | pubmed-author:LynchPeterP | lld:pubmed |
| pubmed-article:20832374 | pubmed:author | pubmed-author:PeoplesTimT | lld:pubmed |
| pubmed-article:20832374 | pubmed:copyrightInfo | Copyright © 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:20832374 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20832374 | pubmed:volume | 4 | lld:pubmed |
| pubmed-article:20832374 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20832374 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20832374 | pubmed:pagination | 209-14 | lld:pubmed |
| pubmed-article:20832374 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:meshHeading | pubmed-meshheading:20832374... | lld:pubmed |
| pubmed-article:20832374 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20832374 | pubmed:articleTitle | Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysis. | lld:pubmed |
| pubmed-article:20832374 | pubmed:affiliation | Medtronic, Inc., Northridge, CA 91325, USA. peter.m.lynch@medtronic.com | lld:pubmed |
| pubmed-article:20832374 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:3039 | entrezgene:pubmed | pubmed-article:20832374 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20832374 | lld:entrezgene |
